Press Releases
April 26, 2025
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Indeterminate
GlobeNewswire, Inc.
March 24, 2025
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
Indeterminate
GlobeNewswire, Inc.
November 20, 2025
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
Indeterminate
GlobeNewswire, Inc.
November 10, 2025
GBSA connects Pangyo’s innovative companies with global media outlets through the 2025 Pangyo Global Media Meet-Up
Neutral
EIN Presswire
December 11, 2025
Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris
Indeterminate
GlobeNewswire, Inc.
August 25, 2025
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Indeterminate
GlobeNewswire, Inc.
November 24, 2025
Chef Andreas Debuts Andreas Prime Steaks & Seafood in Uptown Dallas, Reuniting His Culinary Team from The Palm
Neutral
EIN Presswire
August 12, 2025
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Indeterminate
GlobeNewswire, Inc.
May 15, 2025
Combined General Meeting of June 11, 2025
Indeterminate
GlobeNewswire, Inc.
May 23, 2025
Combined General Meeting of June 13, 2025
Indeterminate
GlobeNewswire, Inc.
May 12, 2025
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Indeterminate
GlobeNewswire, Inc.
May 7, 2025
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Indeterminate
GlobeNewswire, Inc.
September 22, 2025
Public Health Action Network Is A Partnering Organization for the 'Healthy Indoor Air' Event at the UN General Assembly
Neutral
EIN Presswire
July 22, 2025
WHO Cautions Chikungunya Spread Threatens Billions
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
April 18, 2025
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
Indeterminate
GlobeNewswire, Inc.
April 1, 2025
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
Indeterminate
GlobeNewswire, Inc.
March 31, 2025
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
Indeterminate
GlobeNewswire, Inc.
July 22, 2025
EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book
Gov't Institution
ECB - European Central Bank
Owner: European Union